Oxidative Stress Mediates through Apoptosis the Anticancer Effect of Phospho-Nonsteroidal Anti-Inflammatory Drugs: Implications for the Role of Oxidative Stress in the Action of Anticancer Agents

Abstract

We assessed the relationship between oxidative stress, cytokinetic parameters, and tumor growth in response to novel phospho-nonsteroidal anti-inflammatory drugs (NSAIDs), agents with significant anticancer effects in preclinical models. Compared with controls, in SW480 colon and MCF-7 breast cancer cells, phospho-sulindac, phospho-aspirin, phospho-flurbiprofen, and phospho-ibuprofen (P-I) increased the levels of reactive oxygen and nitrogen species (RONS) and decreased GSH levels and thioredoxin reductase activity, whereas the conventional chemotherapeutic drugs (CCDs), 5-fluorouracil (5-FU), irinotecan, oxaliplatin, chlorambucil, paclitaxel, and vincristine, did not. In both cell lines, phospho-NSAIDs induced apoptosis and inhibited cell proliferation much more potently than CCDs. We then treated nude mice bearing SW480 xenografts with P-I or 5-FU that had an opposite effect on RONS in vitro. Compared with controls, P-I markedly suppressed xenograft growth, induced apoptosis in the xenografts (8.9 ± 2.7 versus 19.5 ± 3.0), inhibited cell proliferation (52.6 ± 5.58 versus 25.8 ± 7.71), and increased urinary F2-isoprostane levels (10.7 ± 3.3 versus 17.9 ± 2.2 ng/mg creatinine, a marker of oxidative stress); all differences were statistically significant. 5-FU's effects on tumor growth, apoptosis, proliferation, and F2-isoprostane were not statistically significant. F2-isoprostane levels correlated with the induction of apoptosis and the inhibition of cell growth. P-I induced oxidative stress only in the tumors, and its apoptotic effect was restricted to xenografts. Our data show that phospho-NSAIDs act against cancer through a mechanism distinct from that of various CCDs, underscore the critical role of oxidative stress in their effect, and indicate that pathways leading to oxidative stress may be useful targets for anticancer strategies.

The antioxidant properties of salicylate derivatives: A possible new mechanism of anti-inflammatory activity

“…1 It reduces the risk of many diseases associated with aging, 2 acting via dose-dependent inhibition of arachidonic acid oxidation and prostaglandin production. 3 The enzymatic inhibition of cyclooxygenase (COX) or prostaglandin endoperoxide synthase (PGES) 4 occurs through selective and irreversible acetylation of a single serine residue (Ser 530), an event that inhibits the binding of arachidonic acid. 5 However, at high concentrations and over long periods of time, aspirin will also nonspecifically acetylate a variety of proteins and nucleic acids.…”

Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study

“…We also included oral retinoids (isotretinoin, etretinate) and cyclooxygenase 2 inhibitors and other NSAIDs with potential cancer-preventing effects. [27][28][29][30][31][32] Immunosuppressive drugs were a specific exclusion from this study because the increased risks of skin cancer for patients on long-term immunosuppression are profound. 33,34 To reveal a potential role of dietary furanocoumarins and antioxidants, we included a short dietary section in the questionnaire asking participants to report if they regularly (three or more times per week) took any of the following foods known to contain furanocoumarins: celery, celeriac, parsnips, lemons ⁄limes and carrots.…”

Induction of Apoptosis by the Medium-Chain Length Fatty Acid Lauric Acid in Colon Cancer Cells due to Induction of Oxidative Stress

“…Cancer chemotherapy can induce apoptotic cell death and increased oxidative stress in transformed cells [18]. This is often due to reduced levels of the major antioxidant glutathione (reduced form: GSH) or increased levels of reactive oxygen species (ROS) [19].…”